ORCID
- Gordon Cooke: 0000-0003-0366-3603
Abstract
Rationale: The etiology of cystic fibrosis (CF) pulmonary exacerbations (PEx) is likely multifactorial with viral, bacterial, and non-infectious pathways contributing. Objectives: To determine whether viral infection status and CRP (C-reactive protein) can classify subphenotypes of PEx that differ in outcomes and biomarker profiles. Methods: Patients were recruited at time of admission for a PEx. Nasal swabs and sputum samples were collected and processed using the respiratory panel of the FilmArray multiplex polymerase chain reaction (PCR). Serum and plasma biomarkers were measured. PEx were classified using serum CRP and viral PCR: "pauci-inflammatory" if CRP < 5 mg/L, "non-viral with systemic inflammation" if CRP ⩾ 5 mg/L and no viral infection detected by PCR and "viral with systemic inflammation" if CRP ⩾ 5 mg/L and viral infection detected by PCR. Results: Discovery cohort (n = 59) subphenotype frequencies were 1) pauci-inflammatory (37%); 2) non-viral with systemic inflammation (41%); and 3) viral with systemic inflammation (22%). Immunoglobulin G, immunoglobulin M, interleukin-10, interleukin-13, serum calprotectin, and CRP levels differed across phenotypes. Reduction from baseline in forced expiratory volume in 1 second as percent predicted (FEV1pp) at onset of exacerbation differed between non-viral with systemic inflammation and viral with systemic inflammation (-6.73 ± 1.78 vs. -13.5 ± 2.32%; P = 0.025). Non-viral with systemic inflammation PEx had a trend toward longer duration of intravenous antibiotics versus pauci-inflammation (18.1 ± 1.17 vs. 14.8 ± 1.19 days, P = 0.057). There were no differences in percent with lung function recovery to <10% of baseline FEV1pp. Similar results were seen in local and external validation cohorts comparing a pauci-inflammatory to viral/non-viral inflammatory exacerbation phenotypes. Conclusions: Subphenotypes of CF PEx exist with differences in biomarker profile, clinical presentation, and outcomes.
Keywords
cystic fibrosis, exacerbation, pauci-inflammatory, phenotype, viral infection
DOI Link
Publication Date
2022-11-01
Publication Title
Annals of the American Thoracic Society
Volume
19
Issue
11
ISSN
2325-6621
First Page
1818
Last Page
1826
Deposit Date
2026-05-28
Additional Links
Recommended Citation
Carter, Suzanne C.; Franciosi, Alessandro N.; O'Shea, Kate M.; O'Carroll, Orla M.; Sharma, Ashutosh; Bell, Aoife; Keogan, Brian; O'Reilly, Paul; Coughlan, Suzie; Law, Sheonagh M.; Gray, Robert D.; Hisert, Katherine B.; Singh, Pradeep K.; Cooke, Gordon; Grogan, Brenda; De Gascun, Cillian F.; Gallagher, Charles G.; Nicholson, Trevor T.; Quon, Bradley S.; and McKone, Edward F., "Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic Fibrosis" (2022). Research Outputs: 2025-Present. 18.
https://arrow.tudublin.ie/scschcpsro/18